4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-013741
EVP, CHIEF FINANCIAL OFFICER sold 2,000 shares at $25.00 ($50,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-05-16 | Sale 10b5-1 | −2,000 | $25.00 | $50,000 | 62,130 | D |
| Open-market sales · 2,000 sh · avg $25.00 · $50,000 | |||||||
Loading xslF345X05/form4-05202025_120539.xml…